- Home
- EMX vs XOMA Comparison
EMX vs XOMA Comparison
Compare EMX & XOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EMX
- XOMA
- Stock Information
- Founded
- EMX N/A
- XOMA 1981
- Country
- EMX Canada
- XOMA United States
- Employees
- EMX N/A
- XOMA N/A
- Industry
- EMX
- XOMA Biotechnology: Pharmaceutical Preparations
- Sector
- EMX
- XOMA Health Care
- Exchange
- EMX Nasdaq
- XOMA Nasdaq
- Market Cap
- EMX 338.0M
- XOMA 330.2M
- IPO Year
- EMX N/A
- XOMA N/A
- Fundamental
- Price
- EMX $3.65
- XOMA $32.47
- Analyst Decision
- EMX Strong Buy
- XOMA Strong Buy
- Analyst Count
- EMX 2
- XOMA 2
- Target Price
- EMX $5.38
- XOMA $69.50
- AVG Volume (30 Days)
- EMX 447.8K
- XOMA 57.0K
- Earning Date
- EMX 08-11-2025
- XOMA 08-13-2025
- Dividend Yield
- EMX N/A
- XOMA N/A
- EPS Growth
- EMX N/A
- XOMA N/A
- EPS
- EMX 0.04
- XOMA N/A
- Revenue
- EMX $29,864,000.00
- XOMA $44,952,000.00
- Revenue This Year
- EMX $11.08
- XOMA $82.30
- Revenue Next Year
- EMX $3.72
- XOMA $12.59
- P/E Ratio
- EMX $80.97
- XOMA N/A
- Revenue Growth
- EMX N/A
- XOMA 194.98
- 52 Week Low
- EMX $1.59
- XOMA $18.35
- 52 Week High
- EMX $3.66
- XOMA $35.23
- Technical
- Relative Strength Index (RSI)
- EMX 74.62
- XOMA 61.79
- Support Level
- EMX $3.04
- XOMA $32.60
- Resistance Level
- EMX $3.37
- XOMA $34.60
- Average True Range (ATR)
- EMX 0.12
- XOMA 1.82
- MACD
- EMX 0.03
- XOMA 0.09
- Stochastic Oscillator
- EMX 97.58
- XOMA 66.75
About EMX EMX Royalty Corporation (Canada)
EMX Royalty Corp and its subsidiaries operate as a royalty and prospect generator engaged in exploring for and generating royalties from, metals and minerals properties. The company is a precious, and base metals royalty company. The Company augments royalty generation with royalty acquisitions and strategic investments. EMX's royalty and mineral property portfolio consists of properties in North America, Europe, Turkiye, Latin America, Morocco and Australia.
About XOMA XOMA Corporation
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.